Alkermes plc (ALKS) Reports Second Quarter 2014 Financial Results
7/31/2014 10:38:27 AM
Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2014.
“These quarterly results reflect the strength of our commercial business and the progress we are making to advance Alkermes’ pipeline of innovative CNS medicines. We expect this valuable, late-stage pipeline to fuel significant future growth, and we are in the strong position to drive new product development with robust and reliable revenue streams and significant cash on the balance sheet,” commented James Frates, Chief Financial Officer of Alkermes.
comments powered by